Research Briefing | Apr 27, 2021

Global | Coronavirus Watch: Downside risks ease

Rising global Covid infections remain a key focus, but the recent surge is not automatically grounds for us to slash our near-term forecasts. Indeed, the strength of the initial business and consumer surveys in April potentially lessens the downside risks to the near-term economic outlook.

Vaccine developments over recent months have also clearly reduced uncertainties. Over the past six months, we have pushed up our forecasts for the level of global GDP by the middle of the decade, albeit to a lesser degree than the IMF. But the fund’s especially large revisions compared to ours reflect its previously more pessimistic assessment of the medium-term outlook.

We maintain our view that emerging markets will suffer greater medium-term scarring than advanced economies. But the gap could be narrowed if the pace of vaccine production allows for faster than anticipated rollouts in EMs.

 

Back to Resource Hub

Related Services

US bill next to calculator which says recession

Post

US-China relations improve, yet industrial recession remains likely

For the first time this year, our global industrial production outlook for 2025 has been upgraded. However, we still anticipate an industrial recession in Q2 and Q3.

Find Out More
Industry is performing worse than the broader economy globally

Post

Positive tariff news does little to dispel overall uncertainty

We've nudged up our world GDP growth forecasts for 2025 and 2026 by 0.1ppt to 2.4%, in part to reflect the temporary but substantial reduction in tariffs between the US and China.

Find Out More